title: Should Medicare reimbursement for carotid artery stenting be extended to standard and low risk symptomatic and asymptomatic patients with carotid stenosis?
authors.affiliation: Columbia University College of Physicians and Surgeons, New York, NY, USA. wg2131@columbia.edu
authors.forename: William A
authors.initials: WA
authors.lastname: Gray
authors.forename: Sumaira
authors.initials: S
authors.lastname: Macdonald
authors.forename: Peter A
authors.initials: PA
authors.lastname: Schneider
mesh_terms: D017130:Angioplasty / Q000009:adverse effects / Q000191:economics* / Q000295:instrumentation; D058070:Asymptomatic Diseases; D016893:Carotid Stenosis / Q000175:diagnosis / Q000191:economics* / Q000628:therapy*; D019317:Evidence-Based Medicine / Q000191:economics; D017048:Health Care Costs; D006801:Humans; D007349:Insurance, Health, Reimbursement; D006278:Medicare / Q000191:economics*; D018579:Patient Selection; D018570:Risk Assessment; D012307:Risk Factors; D012720:Severity of Illness Index; D015607:Stents / Q000191:economics*; D014481:United States